Fundraising FoxAceatherapeutics
1 known investors
Find your way into Aceatherapeutics
Sign up to see every warm intro you have to Aceatherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aceatherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ACEA Therapeutics is a clinical-stage pharmaceutical company developing small molecule inhibitors, antibody drug conjugates, and cell therapies to address unmet needs in cancer, autoimmune disease, and COVID-19. The company operates manufacturing and commercial capabilities in China and has multiple candidates in clinical development.
Investors · 1
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Aceatherapeutics do?
- ACEA Therapeutics is a clinical-stage pharmaceutical company developing small molecule inhibitors, antibody drug conjugates, and cell therapies to address unmet needs in cancer, autoimmune disease, and COVID-19. The company operates manufacturing and commercial capabilities in China and has multiple candidates in clinical development.
- Who are Aceatherapeutics's investors?
- Aceatherapeutics's investors include Qiming Venture Partners.